Strata Skin Sciences, Inc.
SSKN
$0.14
$0.014.37%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.97% | -21.23% | -9.15% | 0.86% | 10.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.97% | -21.23% | -9.15% | 0.86% | 10.21% |
| Cost of Revenue | -3.54% | -21.82% | -2.92% | -13.85% | -1.93% |
| Gross Profit | -2.59% | -20.85% | -13.48% | 18.41% | 20.04% |
| SG&A Expenses | -1.25% | -11.72% | 22.42% | -2.83% | 0.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.12% | -15.54% | 10.83% | -8.46% | -2.57% |
| Operating Income | 7,211.76% | -15.70% | -357.61% | 30.25% | 98.53% |
| Income Before Tax | 101.48% | 21.79% | -2,414.14% | 27.79% | -21.59% |
| Income Tax Expenses | 107.06% | -- | -- | -- | -84.78% |
| Earnings from Continuing Operations | 101.27% | 21.79% | -2,414.14% | 27.79% | -20.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 101.27% | 21.79% | -2,414.14% | 27.79% | -20.06% |
| EBIT | 7,211.76% | -15.70% | -357.61% | 30.25% | 98.53% |
| EBITDA | 135.04% | -171.31% | -231.68% | 51.52% | 894.26% |
| EPS Basic | 100.92% | 29.52% | -2,015.96% | 39.30% | -0.75% |
| Normalized Basic EPS | 159.06% | -0.22% | -117.18% | 39.31% | 76.08% |
| EPS Diluted | 101.57% | 29.52% | -2,015.96% | 39.30% | -0.75% |
| Normalized Diluted EPS | 159.06% | -0.22% | -117.18% | 39.31% | 76.08% |
| Average Basic Shares Outstanding | 38.37% | 10.95% | 18.97% | 18.97% | 19.17% |
| Average Diluted Shares Outstanding | 38.37% | 10.95% | 18.97% | 18.97% | 19.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |